Mark Massaro
Stock Analyst at BTIG
(3.63)
# 511
Out of 5,182 analysts
161
Total ratings
40.13%
Success rate
8.65%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $1.12 | +123.21% | 5 | Mar 30, 2026 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $9 → $5 | $6.88 | -27.33% | 8 | Mar 12, 2026 | |
| XGN Exagen | Maintains: Buy | $10 → $9 | $3.08 | +192.21% | 7 | Mar 10, 2026 | |
| BLLN BillionToOne | Maintains: Buy | $160 → $140 | $91.98 | +52.21% | 3 | Mar 5, 2026 | |
| CAI Caris Life Sciences | Maintains: Buy | $45 → $38 | $19.51 | +94.77% | 1 | Feb 27, 2026 | |
| CDNA CareDx | Maintains: Buy | $25 → $26 | $17.92 | +45.09% | 6 | Feb 26, 2026 | |
| TEM Tempus AI | Maintains: Buy | $105 → $90 | $47.50 | +89.47% | 7 | Feb 25, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $200 → $170 | $65.59 | +159.19% | 8 | Feb 24, 2026 | |
| GH Guardant Health | Maintains: Buy | $140 → $145 | $92.84 | +56.18% | 8 | Feb 20, 2026 | |
| PSNL Personalis | Maintains: Buy | $12 → $13 | $6.33 | +105.37% | 5 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $14.84 | +48.25% | 8 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $830 → $800 | $591.84 | +35.17% | 3 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.05 | +241.46% | 10 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $50 | $25.19 | +98.49% | 6 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $260 | $210.83 | +23.32% | 16 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $160 | $119.75 | +33.61% | 4 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $4.86 | +44.03% | 3 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.75 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.18 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $8.22 | +155.47% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.83 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.92 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $128.00 | +134.38% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $198.81 | -43.66% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $274.72 | -39.94% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $15.32 | +422.19% | 9 | Sep 10, 2018 |
Lucid Diagnostics
Mar 30, 2026
Reiterates: Buy
Price Target: $2.5
Current: $1.12
Upside: +123.21%
Ginkgo Bioworks Holdings
Mar 12, 2026
Maintains: Sell
Price Target: $9 → $5
Current: $6.88
Upside: -27.33%
Exagen
Mar 10, 2026
Maintains: Buy
Price Target: $10 → $9
Current: $3.08
Upside: +192.21%
BillionToOne
Mar 5, 2026
Maintains: Buy
Price Target: $160 → $140
Current: $91.98
Upside: +52.21%
Caris Life Sciences
Feb 27, 2026
Maintains: Buy
Price Target: $45 → $38
Current: $19.51
Upside: +94.77%
CareDx
Feb 26, 2026
Maintains: Buy
Price Target: $25 → $26
Current: $17.92
Upside: +45.09%
Tempus AI
Feb 25, 2026
Maintains: Buy
Price Target: $105 → $90
Current: $47.50
Upside: +89.47%
GeneDx Holdings
Feb 24, 2026
Maintains: Buy
Price Target: $200 → $170
Current: $65.59
Upside: +159.19%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $140 → $145
Current: $92.84
Upside: +56.18%
Personalis
Feb 11, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $6.33
Upside: +105.37%
Feb 6, 2026
Maintains: Buy
Price Target: $21 → $22
Current: $14.84
Upside: +48.25%
Feb 3, 2026
Maintains: Buy
Price Target: $830 → $800
Current: $591.84
Upside: +35.17%
Dec 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.05
Upside: +241.46%
Dec 12, 2025
Maintains: Buy
Price Target: $38 → $50
Current: $25.19
Upside: +98.49%
Dec 5, 2025
Maintains: Buy
Price Target: $230 → $260
Current: $210.83
Upside: +23.32%
Dec 3, 2025
Reiterates: Buy
Price Target: $160
Current: $119.75
Upside: +33.61%
Nov 10, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $4.86
Upside: +44.03%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.75
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.18
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $8.22
Upside: +155.47%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.83
Upside: -
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.92
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $128.00
Upside: +134.38%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $198.81
Upside: -43.66%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $274.72
Upside: -39.94%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $15.32
Upside: +422.19%